within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G01A_AntiinfectivesAndAntisepticsExclCombinationsWithCorticosteroids.G01AA10_Clindamycin;

model Clindamycin_1
  extends Pharmacolibrary.Drugs.ATC.G.G01AA10_1;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G01AA10_1</td></tr><td>route:</td><td>intravenous</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Clindamycin is a broad-spectrum lincosamide antibiotic, effective against Gram-positive cocci and anaerobic bacteria. Approved and used in treatment of infections such as MRSA, dental infections, and pelvic inflammatory disease.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetics after intravenous administration in healthy adults (single 600 mg IV dose).</p><h4>References</h4><ol><li><p>Watson, MK, et al., &amp; Chinnadurai, SK (2017). Pharmacokinetics of intravenous clindamycin phosphate in captive Bennett&#x27;s wallabies (Macropus rufogriseus). <i>Journal of veterinary pharmacology and therapeutics</i> 40(6) 682–686. DOI:<a href=&quot;https://doi.org/10.1111/jvp.12421&quot;>10.1111/jvp.12421</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28568310/&quot;>https://pubmed.ncbi.nlm.nih.gov/28568310</a></p></li><li><p>Sullins, AK, &amp; Abdel-Rahman, SM (2013). Pharmacokinetics of antibacterial agents in the CSF of children and adolescents. <i>Paediatric drugs</i> 15(2) 93–117. DOI:<a href=&quot;https://doi.org/10.1007/s40272-013-0017-5&quot;>10.1007/s40272-013-0017-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/23529866/&quot;>https://pubmed.ncbi.nlm.nih.gov/23529866</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Clindamycin_1;
